A 2 Week, Randomized, Double-masked, Controlled, Parallel Group Study to Evaluate Tolerability, Safety, Permanence on the Ocular Surface and Efficacy of Two Concentrations of Lubricin (20 and 50 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients With Ocular Discomfort Following Refractive Surgery

Trial Profile

A 2 Week, Randomized, Double-masked, Controlled, Parallel Group Study to Evaluate Tolerability, Safety, Permanence on the Ocular Surface and Efficacy of Two Concentrations of Lubricin (20 and 50 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients With Ocular Discomfort Following Refractive Surgery

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs Lubricin (Primary) ; Hyaluronic acid
  • Indications Eye disorders
  • Focus Adverse reactions
  • Sponsors Dompe Farmaceutici
  • Most Recent Events

    • 06 Feb 2017 Planned End Date changed from 1 May 2017 to 1 Jun 2017.
    • 06 Feb 2017 Planned primary completion date changed from 1 May 2017 to 1 Jun 2017.
    • 06 Feb 2017 Planned initiation date changed from 1 Jan 2017 to 1 Feb 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top